ArticleClinical medicine (London, England)2026
Trends and widening inequities in cardiovascular-kidney-metabolic involvement in cardiovascular mortality: A national spatiotemporal analysis, 2014-2023.
Article in Clinical medicine (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular-kidney-metabolic (CKM) conditions increasingly contribute to cardiovascular disease (CVD) mortality, but temporal trends in social inequities and geographic priorities remain unclear. We quantified trends, disparities and county-level priority areas for CKM-involved CVD mortality in the USA.
methodsUsing 2014-2023 US vital statistics, we estimated age-standardised CKM-involved CVD mortality. Negative binomial regression estimated Social Vulnerability Index (SVI) quintile-specific relative risks (RRs) and SVI × time interactions. Inequity was measured by the slope (SII) and relative (RII) index of inequality. Bayesian spatiotemporal smoothing identified 2022-2023 county-level RRs and worsening probability (P[increasing]). High-priority areas were defined by current risk (RR ≥ 1.43) and P[increasing] ≥0.80.
resultsNational crude mortality rose from 36.37 per 100,000 (2014-2015) to 47.90 (2022-2023). Disparities significantly widened: the SVI Q5 vs Q1 RR increased from 1.23 (95% CI, 1.18-1.28) to 1.34 (1.29-1.40) (interaction p = 0.0197). Both absolute and relative gradients strengthened (SII: 10.48-21.12; RII: 1.30-1.45). County-level RRs (2022-2023) ranged from 0.24 to 4.87 with regional clustering. Overall, 356 counties (11.4%) were classified as high-risk and worsening. We identified 85 Tier 1 counties and estimated 1,721 national excess deaths.
conclusionsCKM-involved CVD mortality is increasing, and social inequities are widening. Geographically clustered counties face both high current risk and a high likelihood of worsening. These Tier 1 counties represent critical, actionable targets for place-based CKM prevention and treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.